Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
The Analyst
|
July 12, 2001
Dialysis cells for controlled DNA: drug binding studies
K J Sanders, H Wiles, A Rodger
British Journal of Clinical Pharmacology
|
March 1, 1978
Chlorpromazine levels in plasma and milk of nursing mothers
D H Wiles, M W Orr, T Kolakowska
Clinical Chemistry
|
January 1, 1978
Sensitive gas-chromatographic determination of fluphenazine in human plasma
M Franklin, D H Wiles, D J Harvey
Psychopharmacology
|
January 1, 1990
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia
D H Wiles, R G McCreadie, A Whitehead
American Heart Journal
|
October 1, 1989
Fetal and neonatal dysrhythmia associated with a ventricular aneurysm
C Case, H Wiles, P Gillette, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
September 1, 1990
Compliance with antidepressant medication
D Hall, D H Wiles, R G McCreadie
The British Journal of Psychiatry : the Journal of Mental Science
|
June 1, 1992
The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels
R G McCreadie, L J Robertson, D H Wiles
Psychopharmacology
|
January 1, 1985
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients
A C Altamura, S H Curry, S Montgomery, et al.
Psychopharmacology
|
August 26, 1976
Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment
T Kolakowska, D H Wiles, M G Gelder, et al.
Psychological Medicine
|
May 1, 1975
Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients
T Kolakowska, D H Wiles, A S McNeilly, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
The Analyst
|
July 12, 2001
Dialysis cells for controlled DNA: drug binding studies
K J Sanders, H Wiles, A Rodger
British Journal of Clinical Pharmacology
|
March 1, 1978
Chlorpromazine levels in plasma and milk of nursing mothers
D H Wiles, M W Orr, T Kolakowska
Clinical Chemistry
|
January 1, 1978
Sensitive gas-chromatographic determination of fluphenazine in human plasma
M Franklin, D H Wiles, D J Harvey
Psychopharmacology
|
January 1, 1990
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia
D H Wiles, R G McCreadie, A Whitehead
American Heart Journal
|
October 1, 1989
Fetal and neonatal dysrhythmia associated with a ventricular aneurysm
C Case, H Wiles, P Gillette, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
September 1, 1990
Compliance with antidepressant medication
D Hall, D H Wiles, R G McCreadie
The British Journal of Psychiatry : the Journal of Mental Science
|
June 1, 1992
The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels
R G McCreadie, L J Robertson, D H Wiles
Psychopharmacology
|
January 1, 1985
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients
A C Altamura, S H Curry, S Montgomery, et al.
Psychopharmacology
|
August 26, 1976
Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment
T Kolakowska, D H Wiles, M G Gelder, et al.
Psychological Medicine
|
May 1, 1975
Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients
T Kolakowska, D H Wiles, A S McNeilly, et al.
Page
of 3